InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Discover the full record of transactions filed by McCann Corey, 首席执行官. Officer active across 1 company, notably Pear Therapeutics, Inc.. Aggregated, 3 disclosures have been recorded. Breakdown: 0 buy · 1 sell. Total volume traded: €36k. History available since 14 January 2023. The latest transaction was filed on 20 January 2023 (Cession). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 条申报中的 3 条
McCann Corey is the President and CEO of Pear Therapeutics, Inc. He leads the company's operations and strategy, focusing on the development of innovative digital therapies. Corey has significant experience in the healthcare sector, contributing to improving care and innovation within the organization.